Benefits and Risks of Minocycline in Rheumatoid Arthritis

Author： Langevitz P.   Livneh A.   Bank I.   Pras M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.22, Iss.5, 2000-05, pp. : 405-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Newer Biological Agents in the Treatment of Rheumatoid Arthritis: Do the Benefits Outweigh the Risks?

By Nurmohamed Michael T.  

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2035-2043

Adis International

Access to resources Recommend Favorite

Meloxicam in rheumatoid arthritis

By Ahmed Mansoor   Khanna Dinesh   Furst Daniel E  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 739-751

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy in rheumatoid arthritis

By Kller Marcus D  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 329-342

Informa Healthcare

Access to resources Recommend Favorite

Food sensitivity and rheumatoid arthritis

By Gamlin L.   Brostoff J.  

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 1, 1997-11 ,pp. : 43-49

Elsevier

Access to resources Recommend Favorite

Emerging therapies for rheumatoid arthritis

By Jacques Peggy   Van den Bosch Filip  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 231-244

Informa Healthcare

Access to resources Recommend Favorite